123 related articles for article (PubMed ID: 3902658)
1. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
Infection; 1985; 13 Suppl 2():S256-9. PubMed ID: 3902658
[TBL] [Abstract][Full Text] [Related]
2. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
Infection; 1984; 12(4):309-12. PubMed ID: 6386695
[TBL] [Abstract][Full Text] [Related]
3. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.
Stein KE; Söderström T
J Exp Med; 1984 Oct; 160(4):1001-11. PubMed ID: 6384416
[TBL] [Abstract][Full Text] [Related]
4. Serological, chemical, and structural analyses of the Escherichia coli cross-reactive capsular polysaccharides K13, K20, and K23.
Vann WF; Soderstrom T; Egan W; Tsui FP; Schneerson R; Orskov I; Orskov F
Infect Immun; 1983 Feb; 39(2):623-9. PubMed ID: 6187684
[TBL] [Abstract][Full Text] [Related]
5. The effect of monoclonal antibodies against Escherichia coli type 1 pili and capsular polysaccharides on the interaction between bacteria and human granulocytes.
Söderström T; Ohman L
Scand J Immunol; 1984 Oct; 20(4):299-305. PubMed ID: 6150547
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.
Kumar V; Ganguly Nk; Joshi K; Mittal R; Harjai K; Chhibber S; Sharma S
Med Microbiol Immunol; 2005 Aug; 194(4):211-7. PubMed ID: 15909203
[TBL] [Abstract][Full Text] [Related]
7. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
Mattsby-Baltzer I; Hanson LA; Olling S; Kaijser B
Infect Immun; 1982 Feb; 35(2):647-53. PubMed ID: 7035370
[TBL] [Abstract][Full Text] [Related]
8. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
[TBL] [Abstract][Full Text] [Related]
9. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
Kaijser B; Larsson P; Olling S
Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
[TBL] [Abstract][Full Text] [Related]
10. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
Kaijser B; Larsson P; Olling S; Schneerson R
Infect Immun; 1983 Jan; 39(1):142-6. PubMed ID: 6337094
[TBL] [Abstract][Full Text] [Related]
11. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
Colino J; Outschoorn I
Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
[TBL] [Abstract][Full Text] [Related]
12. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
Coughlin RT; Bogard WC
J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
[TBL] [Abstract][Full Text] [Related]
13. Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B.
Moreno C; Hewitt J; Hastings K; Brown D
J Gen Microbiol; 1983 Aug; 129(8):2451-6. PubMed ID: 6415230
[TBL] [Abstract][Full Text] [Related]
14. Structure and serological specificity of the K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli.
Vann WF; Jann K
Infect Immun; 1979 Jul; 25(1):85-92. PubMed ID: 90016
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hurpin CM; Carosella ED; Cazenave PA
Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.
Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P
J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860
[TBL] [Abstract][Full Text] [Related]
17. Protection against experimental pyelonephritis by antibodies to pili.
Silverblatt FJ; Weinstein R; Rene P
Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
[TBL] [Abstract][Full Text] [Related]
18. Antibodies given orally in the neonatal period can affect the immune response for two generations: evidence for active maternal influence on the newborn's immune system.
Lundin BS; Dahlman-Höglund A; Pettersson I; Dahlgren UI; Hanson LA; Telemo E
Scand J Immunol; 1999 Dec; 50(6):651-6. PubMed ID: 10607314
[TBL] [Abstract][Full Text] [Related]
19. Expression of Haemophilus influenzae type b idiotype 1 on naturally acquired antibodies.
Ulanova M; Hahn-Zoric M; Lau YL; Lucas A; Hanson LA
Clin Exp Immunol; 1996 Sep; 105(3):422-8. PubMed ID: 8809129
[TBL] [Abstract][Full Text] [Related]
20. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
